In 2017, Rutgers scientists, working with colleagues from across the world, identified genes whose mutation is a probable risk for Tourette Syndrome. This research team was also the first to use a Nobel Prize winning genetic engineering technique to create brain cells from the blood cells of individuals to further study TS.
These breakthroughs would not be possible if families were not willing to participate in the NJCTS Cell and DNA sharing repository at Rutgers University. The use of this sharing repository in research can lead to everything from new treatments to improve the lives of those with TS to a cure.
You have an opportunity to join NJCTS in this very important work.
Research partner Dr. Robert King, a professor of child psychiatry at the Yale University Medical School and medical director of the TS/OCD Clinic at the Yale University Child Study Center, will be at the NJCTS Cell and DNA Sharing Repository at Rutgers University all day on Thursday and Friday, September 6 and 7, to speak with individuals and families interested in participating in the National Institute of Mental Health NJCTS Genetics Sharing Program.
E-mail firstname.lastname@example.org to schedule your appointment.